photo of J. Michael McIntosh
J. Michael McIntosh
Research Professor, and Professor and Director of Research, Dept. of Psychiatry

mcintosh dot mike at gmail dot com
McIntosh lab web site
McIntosh lab directory

TEACHING

School of Medicine
Psychiatry Clinical Case Conference

School of Medicine
Neuroscience for Psychiatry Residents


Directory
Calendar
BioNews & Reading Frame
Undergraduate Study
Graduate Study
Faculty Research
Programs & Facilities
About the Department

Biology Home

RESEARCH INTERESTS

Receptors and ion channels, Neuroscience, Neuropharmacology
Modulation of neurotransmitter release
Isolation & biochemical characterization of peptides that target nicotinic acetycholine receptors
Functional structure of conotoxins
Nicotinic receptors in Parkinson's Disease
Development of novel medications



PUBLICATIONS


We are interested in the isolation and biochemical characterization of compounds that selectively act on the nervous system. These probes are used to study the structure and function of central nervous system receptors and ion channels in both health and disease states. Structure/function analysis of these ligands provides opportunity for drug development of selected compounds. Currently these compounds are being investigated for the treatment of chronic pain, epilepsy, cardiovascular disorders and neuropsychiatric disorders.

Selected Publications

Kulak, J.M., T.A. Nguyen, B.M. Olivera and J.M. McIntosh (1997) a-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. J. Neurosci. 17:5263-70.

Luo, S., J.M. Kulak, G.E. Cartier, R.B. Jacobsen, D. Yoshikami, B.M. Olivera and J.M. McIntosh (1998) a- Conotoxin AuIB selectively blocks a3b4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J. Neurosci. 18:8571-79.

McIntosh, J.M., A.D. Santos and B.M. Olivera (1999) Conus peptides targeted to specific nicotinic acetylcholine receptor subtypes. Annu. Rev. Biochem. 68:59-88.

Whiteaker, P., J.M. McIntosh, S. Luo, A.C. Collins and M.J. Marks (2000) 125I-a-Conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. Mol. Pharmacol. 57:913-25.

Oppenheim, R.W., D. Prevette, A. D'Costa, S. Wang, L.J. Houenou and J.M. McIntosh (2000) Reduction of neuromuscular activity is required for the rescue of motoneurons from naturally occurring cell death by nicotinic blocking agents. J. Neurosci. 20:6117-24.

Quik, M., Y. Polonskaya, J.M. Kulak and J.M. McIntosh (2001) Vulnerability of 125I-a-conotoxin MII binding sites to nigrostriatal damage in monkeys. J. Neurosci.21(15):5494-5500.



Directory | Calendar | BioNews | Faculty | Graduate Study | Undergraduate Study
Programs & Facilities | About the Department | Biology Home